Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - AccuredReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Roivant Sciences (ROIV) Receivables - Net: 2021-2024

Historic Receivables - Net for Roivant Sciences (ROIV) over the last 4 years, with Dec 2024 value amounting to $678,000.

  • Roivant Sciences' Receivables - Net fell 98.35% to $678,000 in Q4 2024 from the same period last year, while for Dec 2024 it was $678,000, marking a year-over-year decrease of 98.35%. This contributed to the annual value of $678,000 for FY2024, which is 98.35% down from last year.
  • Roivant Sciences' Receivables - Net amounted to $678,000 in FY2024, which was down 83.01% from $4.0 million recorded in FY2024.
  • In the past 5 years, Roivant Sciences' Receivables - Net ranged from a high of $41.1 million in FY2023 and a low of $678,000 during FY2024.
  • Moreover, its 3-year median value for Receivables - Net was $16.0 million (2022), whereas its average is $18.0 million.
  • Per our database at Business Quant, Roivant Sciences' Receivables - Net spiked by 683.37% in 2023 and then tumbled by 98.35% in 2024.
  • Roivant Sciences' Receivables - Net (Yearly) stood at $11.2 million in 2021, then reached $8.9 million in 2021, then plummeted by 65.44% to $3.9 million in 2022, then surged by 213.50% to $28.0 million in 2022, then surged by 683.37% to $30.4 million in 2023, then skyrocketed by 46.88% to $41.1 million in 2023, then crashed by 86.87% to $4.0 million in 2024, then plummeted by 98.35% to $678,000 in 2024.